Review
doi: 10.1176/jnp.1.3.253.
The clinical utility of pharmacological agents that act at serotonin receptors
Affiliations
- PMID: 2562495
- DOI: 10.1176/jnp.1.3.253
Item in Clipboard
Review
The clinical utility of pharmacological agents that act at serotonin receptors
J Neuropsychiatry Clin Neurosci.
1989 Summer.
Abstract
The past decade has seen important advances in the clinical utility of serotonergic agents. The putative novel anxiolytic effects of 5-HT1A partial agonists such as buspirone, the antidepressant effects of selective serotonin (5-HT) uptake blockers such as fluoxetine, and the unique and potent antiemetic effects of 5-HT3 antagonists in cancer chemotherapy are excellent examples of the clinical relevance of selective 5-HT receptor agents. The increasing ability to modulate serotonergic neurotransmission through distinct 5-HT receptor subtypes should greatly facilitate the analysis of 5-HT in both normal and abnormal human brain function.
Similar articles
-
Serotonin receptor and reuptake sites: pharmacologic significance.J Clin Psychiatry. 1990 Apr;51 Suppl:5-12; discussion 13. J Clin Psychiatry. 1990. PMID: 2157701 Review.
-
Serotonin receptor subtypes: implications for psychopharmacology.Br J Psychiatry Suppl. 1991 Sep;(12):7-14. Br J Psychiatry Suppl. 1991. PMID: 1840764 Review.
-
[Central serotonin receptors. Principal fundamental and functional aspects. Therapeutic applications].Rev Neurol (Paris). 1994;150(1):3-15. Rev Neurol (Paris). 1994. PMID: 7801037 Review. French.
-
Serotonin: a common neurobiologic substrate in anxiety and depression.J Clin Psychopharmacol. 1990 Jun;10(3 Suppl):26S-30S. J Clin Psychopharmacol. 1990. PMID: 2198299 Review.
-
Serotonin dysfunction syndromes: a functional common denominator for classification of depression, anxiety, and obsessive-compulsive disorder.Int Clin Psychopharmacol. 1993 Sep;8 Suppl 1:3-14. Int Clin Psychopharmacol. 1993. PMID: 8254151 Review. No abstract available.
Cited by
-
5-HT1A partial agonists. What is their future?Drugs. 1991 Jan;41(1):11-8. doi: 10.2165/00003495-199141010-00002. Drugs. 1991. PMID: 1706983 Review. No abstract available.
-
The pharmacology of lysergic acid diethylamide: a review.CNS Neurosci Ther. 2008 Winter;14(4):295-314. doi: 10.1111/j.1755-5949.2008.00059.x. CNS Neurosci Ther. 2008. PMID: 19040555 Free PMC article. Review.
-
Serotonergic Facilitation of Forelimb Functional Recovery in Rats with Cervical Spinal Cord Injury.Neurotherapeutics. 2021 Apr;18(2):1226-1243. doi: 10.1007/s13311-020-00974-8. Epub 2021 Jan 8. Neurotherapeutics. 2021. PMID: 33420588 Free PMC article.
-
5-HT3 receptor antagonists. An overview of their present status and future potential in cancer therapy-induced emesis.Drugs. 1991 Oct;42(4):551-68. doi: 10.2165/00003495-199142040-00002. Drugs. 1991. PMID: 1723361 Review.
-
Drug treatment of depression in the 1990s. An overview of achievements and future possibilities.Drugs. 1996 Nov;52(5):625-38. doi: 10.2165/00003495-199652050-00001. Drugs. 1996. PMID: 9118813 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
